Haus der Gesundheit

Ludwigshafen 67067

0 studies enrolling now · 2 studies all time

What they study most

Gastroesophageal Reflux Disease, Ulcerative Colitis

Studies at this site

• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) — Completed